Harold J Wanebo

Summary

Affiliation: Roger Williams Medical Center
Country: USA

Publications

  1. doi request reprint Meeting the biologic challenge of colorectal metastases
    Harold J Wanebo
    Division of Surgical Oncology, Landmark Medical Center, Woonsocket, RI, USA
    Clin Exp Metastasis 29:821-39. 2012
  2. ncbi request reprint Targeting growth factors and angiogenesis; using small molecules in malignancy
    Harold J Wanebo
    Department of Surgery, Division Surgical Oncology, Roger Williams Medical Center, Providence, RI, USA
    Cancer Metastasis Rev 25:279-92. 2006
  3. ncbi request reprint Surgical management of pelvic malignancy: role of extended abdominoperineal resection/exenteration/abdominal sacral resection
    Harold J Wanebo
    Boston University Medical School, MA 02118, USA
    Surg Oncol Clin N Am 14:197-224. 2005
  4. ncbi request reprint Isolated chemotherapeutic perfusion of pelvis as neoadjuvant or palliative therapy for advanced cancer of the rectum
    Harold J Wanebo
    Division of Surgical Oncology, Roger Williams Medical Center, Affiliated with Boston University, Providence, Rhode Island, USA
    Ann Surg Oncol 15:1107-16. 2008
  5. doi request reprint The neoadjuvant therapy of colorectal hepatic metastases and the role of biologic sensitizing and resistance factors
    Harold J Wanebo
    Division of Surgical Oncology, Landmark Medical Center, Woonsocket, Rhode Island, USA
    J Surg Oncol 102:891-7. 2010
  6. doi request reprint Selective organ preservation in operable locally advanced head and neck squamous cell carcinomas guided by primary site restaging biopsy: long-term results of two sequential brown university oncology group chemoradiotherapy studies
    Harold J Wanebo
    Division of Surgical Oncology, Landmark Medical Center, Woonsocket, RI, USA
    Ann Surg Oncol 18:3479-85. 2011
  7. doi request reprint Weekly paclitaxel and carboplatin induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck
    Neal E Ready
    Brown University Oncology Group, Providence, RI, USA
    Am J Clin Oncol 35:6-12. 2012
  8. ncbi request reprint Concurrent chemoradiotherapy with weekly paclitaxel and carboplatin for locally advanced head and neck cancer: Long-term follow-up of a Brown University Oncology Group Phase II Study (HN-53)
    Prakash B Chougule
    Department of Radiation Oncology, Rhode Island Hospital, Providence, Rhode Island, USA
    Head Neck 30:289-96. 2008
  9. ncbi request reprint Mucosal melanomas
    John Tomicic
    Boston University, School of Medicine, 715 Albany Street, Boston, MA 02118, USA
    Surg Clin North Am 83:237-52. 2003
  10. doi request reprint Pelvic perfusion for advanced colorectal cancers
    Giovanni Begossi
    Roger Williams Medical Center, Boston University School of Medicine, 825 Chalkstone Avenue, Providence, RI 02908, USA
    Surg Oncol Clin N Am 17:825-42, ix-x. 2008

Collaborators

Detail Information

Publications28

  1. doi request reprint Meeting the biologic challenge of colorectal metastases
    Harold J Wanebo
    Division of Surgical Oncology, Landmark Medical Center, Woonsocket, RI, USA
    Clin Exp Metastasis 29:821-39. 2012
    ..Conclude the final lesson from this well presented mini symposium confirms the need for continued evaluation of the numerous discussion points by clinical trial...
  2. ncbi request reprint Targeting growth factors and angiogenesis; using small molecules in malignancy
    Harold J Wanebo
    Department of Surgery, Division Surgical Oncology, Roger Williams Medical Center, Providence, RI, USA
    Cancer Metastasis Rev 25:279-92. 2006
    ....
  3. ncbi request reprint Surgical management of pelvic malignancy: role of extended abdominoperineal resection/exenteration/abdominal sacral resection
    Harold J Wanebo
    Boston University Medical School, MA 02118, USA
    Surg Oncol Clin N Am 14:197-224. 2005
  4. ncbi request reprint Isolated chemotherapeutic perfusion of pelvis as neoadjuvant or palliative therapy for advanced cancer of the rectum
    Harold J Wanebo
    Division of Surgical Oncology, Roger Williams Medical Center, Affiliated with Boston University, Providence, Rhode Island, USA
    Ann Surg Oncol 15:1107-16. 2008
    ..We currently report our results in 49 recurrent rectal cancer patients (26 had neoadjuvant IPP with intent to resect and 23 had IPP for palliation)...
  5. doi request reprint The neoadjuvant therapy of colorectal hepatic metastases and the role of biologic sensitizing and resistance factors
    Harold J Wanebo
    Division of Surgical Oncology, Landmark Medical Center, Woonsocket, Rhode Island, USA
    J Surg Oncol 102:891-7. 2010
    ..Here, we are discussing the role of biologic agents in the treatment of patients with liver metastases from CRC. We also discuss the role of biomarkers for response and resistance to such novel therapies...
  6. doi request reprint Selective organ preservation in operable locally advanced head and neck squamous cell carcinomas guided by primary site restaging biopsy: long-term results of two sequential brown university oncology group chemoradiotherapy studies
    Harold J Wanebo
    Division of Surgical Oncology, Landmark Medical Center, Woonsocket, RI, USA
    Ann Surg Oncol 18:3479-85. 2011
    ..The long-term outcomes of selective organ preservation in operable, locally advanced head and neck cancers in two sequential chemoradiotherapy (CRT) protocols (HN-53, HN-67) are reported...
  7. doi request reprint Weekly paclitaxel and carboplatin induction chemotherapy followed by concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck
    Neal E Ready
    Brown University Oncology Group, Providence, RI, USA
    Am J Clin Oncol 35:6-12. 2012
    ..To perform a phase II trial evaluating dose dense induction chemotherapy for locally advanced head and neck cancer...
  8. ncbi request reprint Concurrent chemoradiotherapy with weekly paclitaxel and carboplatin for locally advanced head and neck cancer: Long-term follow-up of a Brown University Oncology Group Phase II Study (HN-53)
    Prakash B Chougule
    Department of Radiation Oncology, Rhode Island Hospital, Providence, Rhode Island, USA
    Head Neck 30:289-96. 2008
    ..A phase II study was conducted using concurrent paclitaxel, carboplatin, and external beam radiotherapy (RT) in patients with advanced head and neck cancer...
  9. ncbi request reprint Mucosal melanomas
    John Tomicic
    Boston University, School of Medicine, 715 Albany Street, Boston, MA 02118, USA
    Surg Clin North Am 83:237-52. 2003
    ..Until then, this aggressive tumor continues to have a poor prognosis, and surgical resection continues to be the mainstay of primary therapy...
  10. doi request reprint Pelvic perfusion for advanced colorectal cancers
    Giovanni Begossi
    Roger Williams Medical Center, Boston University School of Medicine, 825 Chalkstone Avenue, Providence, RI 02908, USA
    Surg Oncol Clin N Am 17:825-42, ix-x. 2008
    ....
  11. ncbi request reprint Radical gastrectomy and lymphadenectomy: historic overview, surgical trends, and lessons from the past
    Michael R DiSiena
    Department of Surgery, Roger Williams Medical Center, 825 Chalkstone Avenue, Providence, RI 02908, USA
    Surg Oncol Clin N Am 14:511-32, vi-vii. 2005
  12. ncbi request reprint An effective in vitro antitumor response against human pancreatic carcinoma with paclitaxel and daunorubicin by induction of both necrosis and apoptosis
    James E Gervasoni
    Roger Williams Hospital Boston University, 825 Chalkstone Ave, Providence, Rhode Island 02908, USA
    Anticancer Res 24:2617-26. 2004
    ..6 is more effectively killed following treatment with chemotherapeutic agents that cause death through at least two pathways, a caspase-dependent and caspase-independent apoptosis and necrosis...
  13. doi request reprint Salvage of pelvic recurrence of colorectal cancer
    Kimberly A Varker
    Division of Surgical Oncology, Comprehensive Cancer Center, The Ohio State University Medical Center, Columbus, Ohio, USA
    J Surg Oncol 101:649-60. 2010
    ..For patients with unresectable disease, isolated pelvic perfusion may provide effective palliation...
  14. pmc Factors predictive of the status of sentinel lymph nodes in melanoma patients from a large multicenter database
    Richard L White
    Department of General Surgery, Division of Surgical Oncology, Blumenthal Cancer Center, Carolinas Medical Center, Charlotte, NC, USA
    Ann Surg Oncol 18:3593-600. 2011
    ..This study investigated the significance of factors for predicting regional nodal disease in cutaneous melanoma using a large multicenter database...
  15. ncbi request reprint Capacity of murine IL-12 to inhibit the development of primary melanoma tumors and to prevent lung metastases in the melanoma-challenged mice
    David P Shrayer
    Departments of Surgery and Pathology, Roger Williams Medical Center, Brown University, 825 Chalkstone Avenue, Providence, RI 02908, USA
    J Exp Ther Oncol 2:93-9. 2002
    ..Evaluation of IL-12 therapy on primary tumor growth, mean diameters of primary tumors, survival rate, and development of lung metastases showed that the best results were observed using 300 ng/mouse (15 micrograms/kg) R mIL-12...
  16. doi request reprint Trojan-horse nanotube on-command intracellular drug delivery
    Chia Hsuan Wu
    School of Engineering, Physiology and Biotechnology, Brown University, Providence, Rhode Island 02912, USA
    Nano Lett 12:5475-80. 2012
    ..Nanotube encapsulation permitted the drugs to be used at a 100-fold lower concentration compared to exogenous treatment yet achieve a comparable ~70% cancer kill rate...
  17. ncbi request reprint Changing patterns of failure of head and neck cancer
    Charu Taneja
    Department of Surgery, Roger Williams Medical Center, 825 Chalkstone Ave, Providence, RI 02908, USA
    Arch Otolaryngol Head Neck Surg 128:324-7. 2002
    ..We reviewed the patterns of failure in cancers of the oral cavity, oropharynx, and larynx at our institution during the last decade...
  18. doi request reprint Preface. The evolution of regional therapy modalities
    Harold J Wanebo
    Division of Surgical Oncology, Department of Surgery, Landmark Medical Center, 206 Cass Avenue, Woonsocket, RI 02895, USA
    Surg Oncol Clin N Am 17:xvii-xix. 2008
  19. doi request reprint Regional chemotherapy: overview
    James H Muchmore
    Department of Surgery, Tulane University School of Medicine, 1430 Tulane Avenue, New Orleans, LA 70112, USA
    Surg Oncol Clin N Am 17:709-30, vii. 2008
    ..Newer techniques demonstrate that the combination of regional therapies, hyperthermia, and surgery is essential in promoting improved patient outcomes...
  20. doi request reprint Clinical pharmacokinetics of isolated pelvic perfusion
    James F Belliveau
    Division of Surgical Oncology, Roger Williams Medical Center, Boston University School of Medicine, 825 Chalkstone Avenue, Providence, RI 02908, USA
    Surg Oncol Clin N Am 17:773-84, viii. 2008
    ..Pharmacokinetic modeling using empiric approximations for the kinetic rate constants is a convenient and novel way of fitting data using relatively simple mathematics and commercially available spreadsheets...
  21. ncbi request reprint Isolated pelvic perfusion: plasma pharmacokinetics depend primarily on drug dosage and not the type of drug
    James F Belliveau
    Department of Chemistry, Providence College, 549 River Avenue, Providence, RI, 02918, USA
    Cancer Chemother Pharmacol 55:318-22. 2005
    ..It appears that the pharmacokinetics are sufficiently defined as to predict plasma distribution curves for an additional drug with this protocol. Recent FDA approval of oxaliplatin allowed an evaluation of this premise...
  22. ncbi request reprint Synergistic effect of interleukin-2 and a vaccine of irradiated melanoma cells transfected to secrete staphylococcal enterotoxin A
    David P Schrayer
    Department of Surgery and Pathology, University Medical Group Roger Williams Medical Center, Boston University School of Medicine, Providence, Rhode Island 02908, USA
    Clin Exp Metastasis 19:43-53. 2002
    ..The morphological and immunological effectiveness of the therapy was dose-dependent on IL-2...
  23. ncbi request reprint Cancers of the anal canal and anal margin
    James E Gervasoni
    Department of Surgery, Fox Chase Cancer Center at St Francis Medical Center, Trenton, New Jersey, USA
    Cancer Invest 21:452-64. 2003
  24. ncbi request reprint Phase II study of external irradiation and weekly paclitaxel for nonmetastatic, unresectable pancreatic cancer: RTOG-98-12
    Tyvin Rich
    Department of Radiation Oncology, University of Virginia Health Science Center, Charlottesville, Virginia 22908, USA
    Am J Clin Oncol 27:51-6. 2004
    ..These data provide the basis for a new Radiation Therapy Oncology Group trial using paclitaxel and irradiation combined with a second radiation sensitizer, gemcitabine, now under way...
  25. doi request reprint Editorial regarding use of modified femoral vein approach as method for implanting a totally implantable access port in patients with synchronous bilateral mastectomies (Chen et al.)
    Harold J Wanebo
    J Surg Oncol 98:147. 2008
  26. ncbi request reprint Neoadjuvant therapy with high dose chemotherapy via isolated pelvic intra-abdominal perfusion with bone marrow stem cell support for advanced endometrial cancer
    Meghan Delaney
    University of New England College of Osteopathic Medicine
    Med Health R I 86:252-5. 2003
  27. ncbi request reprint Laparoscopic cholecystectomy: its effect on the prognosis of patients with gallbladder cancer
    Xabier A de Aretxabala
    Department of Surgery, Universidad de La Frontera, German Clinic Temuco, PO Box 54 D Temuco 4781176, Chile
    World J Surg 28:544-7. 2004
    ..Although there is a higher but insignificant recurrence rate among the patients who underwent LC, this is not translated into survival...
  28. ncbi request reprint Targeting small molecules in cancer
    Harold J Wanebo
    Boston University, Boston, MA, USA
    Cancer Treat Res 135:239-55. 2007